Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Mitomycin C is a broad-spectrum antitumor antibiotic isolated and extracted from the culture medium of Streptomyces aureus, which has anticancer effect on many kinds of cancers. Mitomycin C can depolymerize the DNA of cells and inhibit DNA replication, thus inhibiting tumor cell division. Mitomycin C is a non - specific drug for cell cycle.
The global mitomycin C market is expected to witness some growth over the forecast period, achieving a compound annual growth rate of 1.9%. Regionally, China, the United States and other major medical countries will continue to dominate the growth of the global mitomycin C market and will gain the largest market share during the forecast period.
Advances in medical technology and supportive government policies are major drivers of the global mitomycin C market. In addition, mitomycin C is increasingly used in the treatment of cancer and eye diseases, which will further stimulate the market demand for mitomycin C and bring broad prospects for the market.
The report details the trend, potential and market size of Mitomycin C market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Mitomycin Cmarket, defines the market attractiveness level of Mitomycin C market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Mitomycin C industry, describes the types of Mitomycin C market, the applications of major players and the market size, and deeply analyzes the current situation of the global Mitomycin C market and the development prospects and opportunities of Mitomycin C industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Mitomycin C market in Chapter 13.
By Player:
Speciality European Pharma
Teva
Alkem Laboratories
Aspen
Bristol-Myers Squibb
APOGEPHA
Intas Pharmaceuticals
Varifarma
Kyowa-kirin
By Type:
2 Mg
10 Mg
40 Mg
Other
By End-User:
Cancer Treatment
Ophthalmic Use
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Mitomycin C Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Mitomycin C Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Mitomycin C Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Mitomycin C Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Mitomycin C Market Analysis and Outlook to 2022
-
7.1 Global Mitomycin C Consumption (2017-2022)
-
7.2 United States Mitomycin C Consumption (2017-2022)
-
7.3 Europe Mitomycin C Consumption (2017-2022)
-
7.4 China Mitomycin C Consumption (2017-2022)
-
7.5 Japan Mitomycin C Consumption (2017-2022)
-
7.6 India Mitomycin C Consumption (2017-2022)
-
7.7 South Korea Mitomycin C Consumption (2017-2022)
8 Region and Country-wise Mitomycin C Market Analysis and Outlook to 2028
-
8.1 Global Mitomycin C Consumption Forecast (2022-2028)
-
8.2 United States Mitomycin C Consumption Forecast (2022-2028)
-
8.3 Europe Mitomycin C Consumption Forecast (2022-2028)
-
8.4 China Mitomycin C Consumption Forecast (2022-2028)
-
8.5 Japan Mitomycin C Consumption Forecast (2022-2028)
-
8.6 India Mitomycin C Consumption Forecast (2022-2028)
-
8.7 South Korea Mitomycin C Consumption Forecast (2022-2028)
9 Global Mitomycin C Market Outlook by Types and Applications to 2022
-
9.1 Global Mitomycin C Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global 2 Mg Consumption and Growth Rate (2017-2022)
-
9.1.2 Global 10 Mg Consumption and Growth Rate (2017-2022)
-
9.1.3 Global 40 Mg Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Mitomycin C Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Cancer Treatment Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Ophthalmic Use Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Mitomycin C Market Outlook by Types and Applications to 2028
-
10.1 Global Mitomycin C Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global 2 Mg Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global 10 Mg Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global 40 Mg Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Mitomycin C Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Ophthalmic Use Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Mitomycin C Import and Export Analysis (Top 5 Countries)
-
11.1 Global Mitomycin C Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Mitomycin C Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Mitomycin C Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Mitomycin C Market Competitive Analysis
-
14.1 Speciality European Pharma
-
14.1.1 Speciality European Pharma Company Details
-
14.1.2 Speciality European Pharma Mitomycin C Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Speciality European Pharma Mitomycin C Product and Service
-
14.2 Teva
-
14.2.1 Teva Company Details
-
14.2.2 Teva Mitomycin C Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Teva Mitomycin C Product and Service
-
14.3 Alkem Laboratories
-
14.3.1 Alkem Laboratories Company Details
-
14.3.2 Alkem Laboratories Mitomycin C Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Alkem Laboratories Mitomycin C Product and Service
-
14.4 Aspen
-
14.4.1 Aspen Company Details
-
14.4.2 Aspen Mitomycin C Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Aspen Mitomycin C Product and Service
-
14.5 Bristol-Myers Squibb
-
14.5.1 Bristol-Myers Squibb Company Details
-
14.5.2 Bristol-Myers Squibb Mitomycin C Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Bristol-Myers Squibb Mitomycin C Product and Service
-
14.6 APOGEPHA
-
14.6.1 APOGEPHA Company Details
-
14.6.2 APOGEPHA Mitomycin C Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 APOGEPHA Mitomycin C Product and Service
-
14.7 Intas Pharmaceuticals
-
14.7.1 Intas Pharmaceuticals Company Details
-
14.7.2 Intas Pharmaceuticals Mitomycin C Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Intas Pharmaceuticals Mitomycin C Product and Service
-
14.8 Varifarma
-
14.8.1 Varifarma Company Details
-
14.8.2 Varifarma Mitomycin C Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Varifarma Mitomycin C Product and Service
-
14.9 Kyowa-kirin
-
14.9.1 Kyowa-kirin Company Details
-
14.9.2 Kyowa-kirin Mitomycin C Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Kyowa-kirin Mitomycin C Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Mitomycin C
-
Figure Mitomycin C Picture
-
Table Global Mitomycin C Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Mitomycin C Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Mitomycin C Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Mitomycin C Consumption by Country (2017-2022)
-
Figure United States Mitomycin C Consumption and Growth Rate (2017-2022)
-
Table Europe Mitomycin C Consumption and Growth Rate (2017-2022)
-
Figure China Mitomycin C Consumption and Growth Rate (2017-2022)
-
Figure Japan Mitomycin C Consumption and Growth Rate (2017-2022)
-
Figure India Mitomycin C Consumption and Growth Rate (2017-2022)
-
Figure South Korea Mitomycin C Consumption and Growth Rate (2017-2022)
-
Figure Global Mitomycin C Consumption Forecast by Country (2022-2028)
-
Figure United States Mitomycin C Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Mitomycin C Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Mitomycin C Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Mitomycin C Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Mitomycin C Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Mitomycin C Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 2 Mg Consumption and Growth Rate (2017-2022)
-
Figure Global 10 Mg Consumption and Growth Rate (2017-2022)
-
Figure Global 40 Mg Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Ophthalmic Use Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global 2 Mg Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 10 Mg Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 40 Mg Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ophthalmic Use Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Mitomycin C Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Mitomycin C Export by Region (Top 5 Countries) (2017-2028)
-
Table Speciality European Pharma (Foundation Year, Company Profile and etc.)
-
Table Speciality European Pharma Mitomycin C Sales, Price, Value and Gross Profit (2017-2022)
-
Table Speciality European Pharma Mitomycin C Product and Service
-
Table Teva (Foundation Year, Company Profile and etc.)
-
Table Teva Mitomycin C Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Mitomycin C Product and Service
-
Table Alkem Laboratories (Foundation Year, Company Profile and etc.)
-
Table Alkem Laboratories Mitomycin C Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alkem Laboratories Mitomycin C Product and Service
-
Table Aspen (Foundation Year, Company Profile and etc.)
-
Table Aspen Mitomycin C Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aspen Mitomycin C Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Mitomycin C Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Mitomycin C Product and Service
-
Table APOGEPHA (Foundation Year, Company Profile and etc.)
-
Table APOGEPHA Mitomycin C Sales, Price, Value and Gross Profit (2017-2022)
-
Table APOGEPHA Mitomycin C Product and Service
-
Table Intas Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Intas Pharmaceuticals Mitomycin C Sales, Price, Value and Gross Profit (2017-2022)
-
Table Intas Pharmaceuticals Mitomycin C Product and Service
-
Table Varifarma (Foundation Year, Company Profile and etc.)
-
Table Varifarma Mitomycin C Sales, Price, Value and Gross Profit (2017-2022)
-
Table Varifarma Mitomycin C Product and Service
-
Table Kyowa-kirin (Foundation Year, Company Profile and etc.)
-
Table Kyowa-kirin Mitomycin C Sales, Price, Value and Gross Profit (2017-2022)
-
Table Kyowa-kirin Mitomycin C Product and Service
-
